Psoriasis
Latest News
For psoriasis, review finds several biosimilars as safe and effective as biologics
“The biosimilars evaluated in this study could be considered alongside originators for biologic-naive patients to improve the accessibility of...
Feature
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
From the Journals
Methotrexate does not impair sperm quality, small study finds
The findings provide reassurance that men can start methotrexate therapy while actively pursuing parenthood.
Feature
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
SmithRx, which bills itself as “next-generation pharmacy benefits management,” announced that it will offer Yusimry to its members at a discount...
Latest News
How does psoriasis affect fertility and birth outcomes?
“The mechanism to link the higher risk of pregnancy loss in patients with psoriasis is not clear,” the authors wrote.
Latest News
Cell activity in psoriasis may predict disease severity and provide clues to comorbidities
Skin samples from patients with psoriasis showed more fibroblast clusters in the upper layers of the skin in moderate to severe cases.
Commentary
A Joint Effort to Save the Joints: What Dermatologists Need to Know About Psoriatic Arthritis
Dermatologists are in a pivotal position to identify patients affected by psoriatic arthritis and start an appropriate systemic medication.
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
Original Research
An Evaluation of Spin in the Abstracts of Systematic Reviews and Meta-analyses on the Treatment of Psoriasis: A Cross-sectional Analysis
Spin is a way of reporting that distorts the true findings; we sought to investigate the prevalence of spin in systematic review abstracts on...
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
Feature
Axial spondyloarthritis versus axial psoriatic arthritis: Different entities?
Features of axial psoriatic arthritis and axial spondyloarthritis overlap, but whether they’re different diseases or on the same spectrum is...